Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): reversal by physicochemical, alginase, and specific monoclonal antibody treatments
- PMID: 8423085
- PMCID: PMC302764
- DOI: 10.1128/iai.61.2.559-564.1993
Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): reversal by physicochemical, alginase, and specific monoclonal antibody treatments
Abstract
The mucoid exopolysaccharide (MEP or alginate) of Pseudomonas aeruginosa is thought to be a virulence factor for this organism by virtue of its ability to suppress local host defense mechanisms. We purified MEP from clinical isolates of mucoid P. aeruginosa, subjected it to degradation by ultrasonication, heat, alkali, and alginase, and reacted it with monoclonal antibodies specific for MEP epitopes. Partial reversal or complete abrogation of the inhibitory effects of alginate on human neutrophil random migration, chemotaxis, and hexose monophosphate shunt activity and lymphocyte transformation were observed following most of these treatments. Physicochemical analysis of degraded MEP revealed a positive correlation between changes in molecular size and viscosity and loss of biological properties. The biological properties of MEP were also shown to be dependent on the structural integrity of the O-acetyl groups substituted for the mannuronic acid residues. The results show that the capacity of MEP to suppress neutrophil and lymphocyte functions is dependent on its acetyl content and the physical properties of large size and viscosity and may provide part of the explanation for the propensity of mucoid P. aeruginosa to persist in the airways of patients with cystic fibrosis. These findings highlight the important role of MEP as one of the virulence factors in the pathogenesis of inflammatory damage and subsequent pulmonary destruction in cystic fibrosis.
Similar articles
-
Alginase treatment of mucoid Pseudomonas aeruginosa enhances phagocytosis by human monocyte-derived macrophages.Infect Immun. 1988 Nov;56(11):2788-93. doi: 10.1128/iai.56.11.2788-2793.1988. Infect Immun. 1988. PMID: 3139564 Free PMC article.
-
Inhibition of adherence of mucoid Pseudomonas aeruginosa by alginase, specific monoclonal antibodies, and antibiotics.Infect Immun. 1993 Oct;61(10):4338-43. doi: 10.1128/iai.61.10.4338-4343.1993. Infect Immun. 1993. PMID: 8406822 Free PMC article.
-
Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa.Infect Immun. 1991 Jan;59(1):302-8. doi: 10.1128/iai.59.1.302-308.1991. Infect Immun. 1991. PMID: 1898898 Free PMC article.
-
Pseudomonas aeruginosa biofilms: role of the alginate exopolysaccharide.J Ind Microbiol. 1995 Sep;15(3):162-8. doi: 10.1007/BF01569821. J Ind Microbiol. 1995. PMID: 8519473 Review.
-
Pseudomonas aeruginosa: genes and enzymes of alginate synthesis.Trends Microbiol. 1994 May;2(5):151-7. doi: 10.1016/0966-842x(94)90664-5. Trends Microbiol. 1994. PMID: 8055178 Review.
Cited by
-
Simple sequence repeats and mucoid conversion: biased mucA mutagenesis in mismatch repair-deficient Pseudomonas aeruginosa.PLoS One. 2009 Dec 7;4(12):e8203. doi: 10.1371/journal.pone.0008203. PLoS One. 2009. PMID: 19997602 Free PMC article.
-
Enzymatic modifications of exopolysaccharides enhance bacterial persistence.Front Microbiol. 2015 May 15;6:471. doi: 10.3389/fmicb.2015.00471. eCollection 2015. Front Microbiol. 2015. PMID: 26029200 Free PMC article. Review.
-
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.Microbiol Rev. 1996 Sep;60(3):539-74. doi: 10.1128/mr.60.3.539-574.1996. Microbiol Rev. 1996. PMID: 8840786 Free PMC article. Review.
-
Specific Disruption of Established Pseudomonas aeruginosa Biofilms Using Polymer-Attacking Enzymes.Langmuir. 2020 Feb 18;36(6):1585-1595. doi: 10.1021/acs.langmuir.9b02188. Epub 2020 Feb 7. Langmuir. 2020. PMID: 31990563 Free PMC article.
-
Innate Immune Signaling Activated by MDR Bacteria in the Airway.Physiol Rev. 2016 Jan;96(1):19-53. doi: 10.1152/physrev.00009.2015. Physiol Rev. 2016. PMID: 26582515 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources